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https://doi.org/10.1016/j.ajic.2019.01.018All invasive procedures involve contact by a medical device or surgical instrument with a patient’s sterile tis-
sue or mucous membranes. The level of disinfection or sterilization is dependent on the intended use of the
object. Critical (items that contact sterile tissue, such as surgical instruments), semicritical (items that contact
mucous membranes, such as endoscopes), and noncritical (devices that contact only intact skin, such as
stethoscopes) items require sterilization, high-level disinfection, and low-level disinfection, respectively.
Cleaning must always precede high-level disinfection and sterilization.
Antiseptics are essential to infection prevention as part of a hand hygiene program, as well as other uses,
such as surgical hand antisepsis and preoperative skin preparation.Disinfection
Sterilization
AntisepsisPH, CIC, Division of Infectious
e, 130 Mason Farm Rd, Bioin-
and ASP. Dr. Weber is a con-Each year in the United States, there are approximately
53,000,000 outpatient surgical procedures and 46,000,000 inpatient
surgical procedures.1 For example, there are at least 18 million gas-
trointestinal endoscopies per year.2 Each of these procedures involves
contact by a medical device or surgical instrument with a patient’s
sterile tissue or mucous membranes. A major risk of all such proce-
dures is the introduction of infection. Failure to properly disinfect or
sterilize medical devices and surgical instruments may lead to trans-
mission via these devices (eg, endoscopes contaminated with carba-
penem-resistant Enterobacteriaceae).3
Achieving disinfection and sterilization by disinfectants and steril-
ization practices is essential for ensuring that medical and surgical
instruments do not transmit infectious pathogens to patients. Health
care policies must identify whether cleaning, disinfection, or steriliza-
tion is indicated based primarily on the items’ intended use. This arti-
cle will capsulize and update other articles on this subject as well as
provide updated information regarding newer sterilization, disinfec-
tion, and antisepsis technologies and practices.4-7
A RATIONAL APPROACH TO DISINFECTION AND STERILIZATION
Fifty years ago, Spaulding8 devised a rational approach to disinfec-
tion and sterilization of patient care items and equipment. Thisclassification scheme is so clear and logical that it has been retained,
refined, and successfully used by infection control professionals and
others when planning methods for disinfection and sterilization.4-10
Spaulding believed that the nature of disinfection could be under-
stood more readily if instruments and items for patient care were
divided into 3 categories based on the degree of risk of infection
involved in the use of the items. The 3 categories he described were
critical (enters sterile tissue and must be sterile), semicritical (con-
tacts mucous membranes or nonintact skin and requires high-level
disinfection), and noncritical (comes in contact with intact skin and
requires low-level disinfection). These categories and the methods to
achieve sterilization, high-level disinfection, and low-level disinfec-
tion are summarized in Table 1. Although the scheme remains valid,
there are some examples of disinfection studies with prions, viruses,
mycobacteria, and protozoa that challenge the current definitions
and expectations of high- and low-level disinfection.11
Critical items
Critical items are so-called because of the high risk of infection if
such an item is contaminated with any microorganism, including bac-
terial spores. Thus, it is critical that objects that enter sterile tissue or
the vascular system be sterile because any microbial contamination
could result in disease transmission. This category includes surgical
instruments, cardiac and urinary catheters, and implants. The items in
this category should be purchased as sterile or sterilized by steam ster-
ilization, if possible. If heat-sensitive, the object may be treated with
ethylene oxide, hydrogen peroxide gas plasma, vaporized hydrogen
peroxide, hydrogen peroxide vapor and ozone, or liquid chemical
Table 1
Methods for disinfection and sterilization of patient care items and environmental surfaces*
Process
Level of microbial








Steam (»40 min), dry heat (1-6 h, depending on
temperature)
Ethylene oxide gas (»15 h), HP gas plasma
(28-38 min, NX), HP and ozone (46-70 min,
VP4), HP vapor (28-55 min, V-PRO maX)
Chemical sterilantsz: >2% glut (»10 h at
20°C-25°C), 1.12% glut with 1.93% phenol
(12 h at 25°C), 7.35% HP with 0.23% PA (3 h
at 20°C), 7.5% HP (6 h at 20°C), 1.0% HP
with 0.08% PA (8 h at 20°C), »0.2% PA
(12 min at 50°C-56°C)
Heat-tolerant critical (surgical instru-
ments) and semicritical patient care
items
Heat-sensitive critical and semicritical
patient care items
Heat-sensitive critical and semicritical










Pasteurization (65°C-77°C, 30 min)
Chemical sterilants/HLDsz: >2% glut (20-90 min
at 20°C-25°C), >2% glut (5 min at 35°C), 0.55%
OPA (12 min at 20°C), 1.12% glut with 1.93%
phenol (20 min at 25°C), 7.35% HP with 0.23%
PA (15 min at 20°C), 7.5% HP (30 min at 20°C),
1.0% HP with 0.08% PA (25 min at 20°C), 650-
675 free chlorine (10 min at 25°C), 2.0% HP
(8 min at 20°C), 3.4% glut with 20.1% isopropa-
nol (5 min at 25°C)
Heat-sensitive semicritical items (eg,
respiratory therapy equipment)
Heat-sensitive semicritical items (eg,









Liquid contact EPA-registered hospital disinfectant with no
tuberculocidal claim (eg, chlorine-based prod-
ucts, phenolics, improved HP, HP plus PA,
quats, quats plus alcohol, or 70%-90% alcohol.
Exposure time ≥1 min)
Noncritical patient care items (eg, blood
pressure cuffs) or surfaces (eg, bedside
tables) with no visible blood
AER, automated endoscope reprocessor; EPA, Environmental Protection Agency; FDA, Food and Drug Administration; GI, gastrointestinal; glut, glutaraldehyde; HLD, high-level disin-
fectant; HP, hydrogen peroxide; NX, next generation; OPA, ortho-phthalaldehyde; PA, peracetic acid; quats, quaternary ammonium compounds.
*Modified from Rutala andWeber4-10,46-48 and Kohn et al.49
yPrions (eg, Creutzfeldt-Jakob disease) exhibit an unusual resistance to conventional chemical and physical decontamination methods and are not readily inactivated by conven-
tional sterilization procedures.50
zConsult the FDA-cleared package insert for information about the cleared contact time and temperature and see reference 5 for discussion regarding why >2% glut products are
used at a reduced exposure time (2% glut at 20 min, 20°C). Increasing the temperature using an AER will reduce contact time (eg, OPA 12 min at 20°C but 5 min at 25°C in AER).
Exposure temperatures for some HLDs listed above vary from 20°C to 25°C; check FDA-cleared temperature conditions.24 Tubing must be completely filled for high-level disinfec-
tion and liquid chemical sterilization. Material compatibility should be investigated when appropriate (eg, HP and HP with PA may cause functional damage to endoscopes). Inter-
mediate-level disinfectants destroy vegetative bacteria, mycobacteria, most viruses, and most fungi, but not spores, and may include chlorine-based products, phenolics, and
improved HP. Intermediate-level disinfectants are not included in Table 1, as there is no device or surface for which intermediate-level disinfection is specifically recommended
over low-level disinfection.sterilants, if other methods are unsuitable. Tables 1-3 list sterilization
processes, high-level disinfectants, and liquid chemical sterilants and
the advantages and disadvantages of each. With the exception of 0.2%
peracetic acid (12 minutes at 50°C-56°C), the indicated exposure times
for liquid chemical sterilants range from 3 to 12 hours. Liquid chemical
sterilants can be relied on to produce sterility only if cleaning, which
eliminates organic and inorganic material, precedes treatment and if
proper guidelines as to concentration, contact time, temperature, and
pH are met. Another limitation to sterilization of devices with liquid
chemical sterilants is that the devices cannot be wrapped during proc-
essing in a liquid chemical sterilant; thus, it is impossible to maintain
sterility following processing and during storage. Furthermore, devices
may require rinsing following exposure to the liquid chemical sterilant
with water that, in general, is not sterile. Therefore, because of the
inherent limitations of using liquid chemical sterilants in a nonauto-
mated (or automated) reprocessor, their use should be restricted to
reprocessing critical devices that are heat-sensitive and incompatible
with other sterilization methods.
Sterilization technologies can be relied on to produce sterility only
if cleaning—to eliminate organic and inorganic material as well as
microbial load—precedes treatment.12-14 Other issues sterile reproc-
essing and operating room professionals must deal with when
reprocessing instruments include weight limits for instrument trays,
wet packs, packaging, loaned instruments, cleaning monitoring, and
water quality.14,15
In May 2015, the Food and Drug Administration (FDA) convened a
panel to discuss recent reports and epidemiologic investigations of thetransmission of infections associated with the use of duodenoscopes in
endoscopic retrograde cholangiopancreatography procedures.16 After
presentations from industry, professional societies, and invited speak-
ers, the panel made several recommendations, to include reclassifying
duodenoscopes based on the Spaulding classification from semicritical
to critical to support the shift from high-level disinfection to steriliza-
tion. This could be accomplished by shifting from high-level disinfec-
tion for duodenoscopes to sterilization and modifying the Spaulding
definition of critical items from “objects which enter sterile tissue or
the vascular system or through which blood flows should be sterile” to
“objects which directly or indirectly (ie, via a mucous membrane such
as duodenoscope) enter normally sterile tissue of the vascular system
or through which blood flows should be sterile.”3,17-19 It is noteworthy
that in the Spaulding scheme, which identifies how an object should be
disinfected or sterilized, he stated that mucous membranes should be
intact and that sterilization of semicritical items is desirable.8 Imple-
mentation of this recommendation requires sterilization technology
that achieves a sterility assurance level of 10¡6 of complex medical
instruments such as duodenoscopes. Ideally, this shift would eventu-
ally involve not only endoscopes that indirectly enter normally sterile
tissue (eg, duodenoscopes, bronchoscopes) but also other semicritical
devices (eg, gastrointestinal endoscopes).17
Semicritical items
Semicritical items are those that come in contact with intact
mucous membranes or nonintact skin. Respiratory therapy and
Table 2
Summary of advantages and disadvantages of chemical agents used as chemical sterilants or HLDs*
Sterilization method Advantages Disadvantages
PA/HP  No activation required Material compatibility concerns (lead, brass, copper, zinc),
both cosmetic and functional
 Limited clinical experience
Mucous membrane and respiratory health effects
 Potential for eye and skin damage
Glut  Numerous use studies published
 Relatively inexpensive
 Excellent material compatibility
 Respiratory irritation from glut vapor
 Pungent and irritating odor
 Relatively slow mycobactericidal activity (unless other dis-
infectants added, eg, phenolics, alcohol)
 Coagulates blood and fixes tissue to surfaces
 Allergic contact dermatitis
 ACGIH recommends limiting employee exposure to ceiling
concentration of 0.05 ppm
HP (standard)  No activation required
May enhance removal of organic matter and organisms
 No disposal issues
 No odor or irritation issues
 Does not coagulate blood or fix tissues to surfaces
 Inactivates Cryptosporidium at 6%-7.5%
 Use studies published
Material compatibility concerns (brass, zinc, copper, and
nickel/silver plating), both cosmetic and functional
 Serious eye damage with contact
OPA  Fast-acting HLD
 No activation required
 Odor not significant
 Excellent materials compatibility claimed
 Does not coagulate blood or fix tissues to surfaces (claimed)
 Relatively rapid mycobactericidal activity
 Stains protein gray (eg, skin, mucous membranes, clothing,
environmental surfaces)
More expensive than glut
 Eye irritation with contact
 Slow sporicidal activity
 Anaphylactic reactions to OPA in bladder cancer patients
with repeated exposure to OPA through cystoscopy
PA  Standardized cycle (eg, liquid chemical sterilant processing system using
PA, rinsed with extensively treated potable water)
 Low-temperature (50°C-55°C) liquid immersion sterilization
 Environmentally friendly by-products (acetic acid, O2, H2O)
 Fully automated
 Single-use system eliminates need for concentration testing
May enhance removal of organic material and endotoxin
 No adverse health effects to operators under normal operating condi-
tions
 Compatible with many materials and instruments
 Does not coagulate blood or fix tissues to surfaces
 Sterilant flows through scope, facilitating salt, protein, and microbe
removal
 Rapidly sporicidal
 Provides procedure standardization (constant dilution, perfusion of
channel, temperature, exposure)
 Potential material incompatibility (eg, aluminum anodized
coating becomes dull)
 Used for immersible instruments only
 Biological indicator may not be suitable for routine
monitoring
 One scope or a small number of instruments can be
processed in a cycle
More expensive (endoscope repairs, operating costs,
purchase costs) than high-level disinfection
 Serious eye and skin damage (concentrated solution) with
contact
 Point-of-use system, no sterile storage
 AER using 0.2% PA not FDA cleared as sterilization process
but as HLD
Improved HP (2.0%), HLD  No activation required
 No odor
 Nonstaining
 No special venting requirements
Manual or automated applications
 12-month shelf life, 14-day reuse
 8 min at 20°C HLD claimed
Material compatibility concerns because of limited clinical
experience
 Organic material resistance concerns because of limited data
NOTE. All products are effective in the presence of organic soil, are relatively easy to use, and have a broad spectrum of antimicrobial activity (bacteria, fungi, viruses, bacterial
spores, and mycobacteria). The above characteristics are documented in the literature; contact the manufacturer of the instrument and HLD/chemical sterilant for additional infor-
mation. All products listed above are FDA cleared as chemical sterilants, except OPA and 2% accelerated HP, which are FDA-cleared HLDs.
ACGIH, American Conference of Governmental Industrial Hygienists; AER, automated endoscope reprocessor; FDA, Food and Drug Administration; glut, glutaraldehyde; HLD, high-
level disinfectant; HP, hydrogen peroxide; OPA, ortho-phthalaldehyde; PA, peracetic acid.
*Modified from Rutala andWeber.4-10,46-48anesthesia equipment, some endoscopes, laryngoscope blades and
handles,20,21 esophageal manometry probes, endocavitary probes,
nasopharyngoscopes, prostate biopsy probes,22 infrared coagulation
devices,23 anorectal manometry catheters, cystoscopes, and dia-
phragm fitting rings are included in this category.20 These medical
devices should be free of all microorganisms, although small numbers
of bacterial spores may be present. FDA’s definition of high-level dis-
infection is a sterilant used for a shorter contact time to achieve at
least a 6 log10 kill of an appropriate Mycobacterium species. Cleaning
followed by high-level disinfection should eliminate all pathogens
capable of causing infection.
Intact mucous membranes, such as those of the lungs or the
gastrointestinal tract, generally are resistant to infection bycommon bacterial spores but susceptible to other organisms, such
as bacteria, mycobacteria, and viruses. Semicritical items minimally
require high-level disinfection using chemical disinfectants. Glutar-
aldehyde, hydrogen peroxide, ortho-phthalaldehyde, peracetic
acid, hypochlorite (via superoxidized water), and peracetic acid
with hydrogen peroxide are cleared by the FDA24 and are depend-
able high-level disinfectants provided the factors influencing ger-
micidal procedures are met (Tables 1 and 2). The exposure time for
most high-level disinfectants varies from 8 to 45 minutes at 20°C-
25°C. When a disinfectant is selected for use with certain patient
care items, the chemical compatibility after extended use with the
items to be disinfected must also be considered. The reprocessing
of semicritical items such as endoscopes, laryngoscopes, and
Table 3
Summary of advantages and disadvantages of commonly used sterilization technologies*
Sterilization method Advantages Disadvantages
Steam  Nontoxic to patient, staff, environment
 Cycle easy to control and monitor
 Rapidly microbicidal
 Least affected by organic/inorganic soils among sterilization pro-
cesses listed
 Rapid cycle time
 Penetrates medical packing, device lumens
 Deleterious to heat-sensitive instruments
Microsurgical instruments damaged by repeated exposure
May leave instruments wet, causing them to rust
 Potential for burns
HP gas plasma  Safe for the environment and health care personnel
 Leaves no toxic residuals
 Cycle time 28-38 min and no aeration necessary
 Used for heat- and moisture-sensitive items since process tem-
perature <50°C
 Simple to operate, install (208-V outlet), and monitor
 Compatible with most medical devices
 Requires only electrical outlet
Microbicidal efficacy data
 Cellulose (paper), linens, and liquids cannot be processed
 Endoscope and other medical device restrictions based on lumen internal
diameter and length (eg, single- and dual-channel device with stainless steel
lumen that is ≥1.0 mm in internal diameter and ≤150 mm in length; see
manufacturer’s recommendations)
 Requires synthetic packaging (polypropylene wraps, polyolefin pouches) and
special container tray
 HP may be toxic at levels greater than 1 ppm TWA
 Organic matter reduces microbicidal activity
100% ETO  Penetrates packaging materials, device lumens
 Single-dose cartridge and negative-pressure chamber minimize
the potential for gas leak and ETO exposure
 Simple to operate and monitor
 Compatible with most medical materials
 Requires aeration time to remove ETO residue
 ETO is toxic, a probable carcinogen, and flammable
 ETO emissions regulated by states, but catalytic cell removes 99.9% of ETO
and converts it to CO2 and H2O
 ETO cartridges should be stored in flammable liquid storage cabinet
 Lengthy cycle/aeration time
 Organic matter reduces microbicidal activity
Vaporized HP  Safe for environment and health care personnel
 Leaves no toxic residue, no aeration necessary
 Cycle time 28-55 min
 Used for heat- and moisture-sensitive items (metal and non-
metal devices)
Medical device restrictions based on lumen internal diameter and length (eg,
single-channel device with stainless steel lumen that is ≥0.7 mm in internal
diameter and ≤500 mm in length; see manufacturer’s recommendations)
 Not used for liquid, linens, powders, or any cellulose materials
 Requires synthetic packaging (polypropylene)
 Limited materials compatibility data
 Limited clinical use data
 Limited comparative microbicidal efficacy data
 Organic matter reduces microbicidal activity
HP and ozone  Safe for environment and health care personnel
 Uses dual sterilants, HP and ozone
 No aeration needed because of no toxic by-products
 Compatible with common medical devices
 Cycle time 46-70 min
 FDA cleared for general instruments and multichannel flexible
endoscopes (see manufacturer’s instructions)
 Endoscope and other medical device restrictions based on lumen internal
diameter and length (eg, single- and dual-channel device with stainless steel
lumen that is ≥0.7 mm in internal diameter and ≤500 mm in length; see
manufacturer’s recommendations)
 Limited clinical use data
 Limited materials compatibility data
 Limited microbicidal efficacy data
 Requires synthetic packaging (polypropylene wraps, polyolefin pouches) and
special container tray
 Organic matter reduces microbicidal activity
ETO, ethylene oxide; FDA, Food and Drug Administration; HP, hydrogen peroxide; TWA, time-weighted average.
*Modified from Rutala andWeber.4-10,46-48nasopharyngoscopes is discussed in detail in another article in this
journal.25
Since semicritical equipment has been associated with reprocess-
ing errors that result in patient look-back and patient notifications, it
is essential that control measures be instituted to prevent patient
exposures.26 Before new equipment (especially semicritical equip-
ment, as the margin of safety is less than that for sterilization)3 is
used for patient care on more than one patient, reprocessing proce-
dures for that equipment should be developed. Staff should receive
training on the safe use and reprocessing of the equipment and be
competency tested. At University of North Carolina Hospitals, to
ensure patient-safe instruments, all staff who reprocess semicritical
instruments (eg, instruments that contact a mucous membrane,
including vaginal probes, endoscopes, prostate probes) are required
to attend a 3-hour class on high-level disinfection of these instru-
ments. The class includes the rationale for and importance of high-
level disinfection and a discussion of high-level disinfectants and
exposure times, reprocessing steps, monitoring minimum effective
concentration, personal protective equipment, and the reprocessing
environment (establishing “dirty-to-clean” flow). Infection control
rounds or audits should be conducted at least annually in all clinical
areas that reprocess critical and semicritical devices to ensureadherence to reprocessing standards and policies. Results of infection
control rounds should be provided to unit managers, and deficiencies
in reprocessing should be corrected (immediately, if patient safety
issue, such as no brushing of channels) and corrective measures docu-
mented to infection control within 2 weeks.
Some items that may come in contact with nonintact skin for a
brief period of time (eg, hydrotherapy tanks, ultrasound probes on
intact skin [includes central line puncture site]) are usually consid-
ered noncritical surfaces and are disinfected with low- or intermedi-
ate-level disinfectants.5,27,28 Since hydrotherapy tanks have been
associated with spread of infection, some facilities have chosen to dis-
infect themwith recommended levels of chlorine.5,27
Noncritical items
Noncritical items are those that come in contact with intact skin
but not mucous membranes. Intact skin acts as an effective barrier to
most microorganisms; therefore, the sterility of items coming in con-
tact with intact skin is “not critical.” Examples of noncritical items are
bedpans, blood pressure cuffs, crutches, bed rails, bedside tables,
patient furniture, toys,29 portable equipment (eg, wheelchairs, infu-
sion pumps, pulse oximeters, medication carts),30,31 and floors.32,33
Table 4
Summary of advantages and disadvantages of disinfectants used as low-level disinfectants*
Disinfectant active Advantages Disadvantages




 Used to disinfect small surfaces (eg, rubber stoppers on medica-
tion vials)
 No toxic residue
 Not sporicidal
Microbicidal activity affected by organic matter
 Slow-acting against nonenveloped viruses (eg, norovirus)
 No detergent or cleaning properties
 Not EPA registered
 Damages some instruments (eg, hardens rubber,
deteriorates glue)
 Flammable (large amounts require special storage)
 Evaporates rapidly, making contact time compliance
difficult
 Not recommended for use on large surfaces
 Outbreaks ascribed to contaminated alcohol51
Sodium hypochlorite
(chlorine)
 Bactericidal, tuberculocidal, fungicidal, virucidal
 Sporicidal (in high concentrations)
 Fast-acting
 Inexpensive (in dilutable form)
 Not flammable
 Unaffected by water hardness
 Reduces biofilms on surfaces
 Relatively stable (eg, 50% reduction in chlorine concentration in
30 d52
 Used as the disinfectant in water treatment
 EPA registered
 Reaction hazard with acids and ammonias
 Leaves salt residue
 Corrosive to metals (some ready-to-use products may be
formulated with corrosion inhibitors)
 Unstable active (some ready-to-use products may be
formulated with stabilizers to achieve longer shelf life)
Microbicidal activity affected by organic matter
 Discolors/stains fabrics
 Potential hazard is production of trihalomethane
May cause skin and eye irritation
 Odor (some ready-to-use products may be formulated with
odor inhibitors)
 Irritating at high concentrations
Improved (or acceler-
ated) HP
 Bactericidal, tuberculocidal, fungicidal, virucidal
 Fast efficacy
 Easy compliance with wet treatment times
 Safe for workers (lowest EPA toxicity category of IV)




More expensive than most other disinfecting actives
 Not sporicidal at low concentrations
 Some material compatibility issues
Iodophors  Bactericidal, mycobactericidal, virucidal
 Not flammable
 Used for disinfecting blood culture bottles
 Not sporicidal
 Shown to degrade silicone catheters
 Require prolonged contact to kill fungi
 Stain surfaces
 Used mainly as antiseptics rather than disinfectants
Phenolics  Bactericidal, tuberculocidal, fungicidal, virucidal





 Absorbed by porous materials and irritate tissue
 Depigmentation of skin caused by certain phenolics






 Bactericidal, fungicidal, virucidal against enveloped viruses
(eg, HIV)




 Persistent antimicrobial activity when undisturbed
 Inexpensive (in dilutable form)
 Not sporicidal
 In general, not tuberculocidal or virucidal against nonenvel-
oped viruses
 High water hardness can make less microbicidal
 A few reports documented asthma as a result of exposure to
benzalkonium chloride
Microbicidal activity affected by organic matter
 Absorption by cotton may diminish microbicidal activity
Multiple outbreaks ascribed to contaminated benzalkonium
chloride51
Alcohol and quat  Bactericidal, tuberculocidal, fungicidal, virucidal (enveloped





 Persistent antimicrobial activity when undisturbed
 EPA registered
 Not sporicidal
 Evaporate more rapidly than water-based disinfectants
PA/HP  Bactericidal, fungicidal, virucidal, sporicidal (eg, C difficile)
 Active in the presence of organic material
 Environmentally friendly by-products (acetic acid, O2, H2O)
 EPA registered
 Surface compatible
 Lack of stability
 Potential for material incompatibility (eg, brass, copper)
More expensive than most other disinfecting actives
 Odor may be irritating
 Can cause mucous membrane and respiratory health effects
NOTE. If low-level disinfectant is prepared on site (not ready to use), document correct concentration at a routine frequency, as the concentration delivered by automated disinfec-
tant dispensers varies.
C difficile, Clostridium difficile; EPA, Environmental Protection Agency; HP, hydrogen peroxide; PA, peracetic acid; quat, quaternary ammonium compound.
*Modified from Rutala andWeber.4-10,46-52
Table 5





bacteria Mycobacteria Fungi Viruses Speed of action Comments
Alcohols +++ +++ +++ +++ +++ Fast Optimum concentration 60%-
95%, no persistent activity
Chlorhexidine
(2%-4% aqueous)
+++ ++ + + +++ Intermediate Persistent activity, rare allergic
reactions, not compatible with
some anionic and nonionic
detergents, ototoxicity
Iodine compounds +++ +++ +++ ++ +++ Intermediate Cause skin burns, usually too
irritating for hand hygiene
Iodophors +++ +++ + ++ ++ Intermediate Less irritating than iodine
Phenol derivative (eg, PCMX) +++ + + + + Intermediate Not compatible with nonionic
detergents, ecologic concerns
Triclosan +++ ++ + - +++ Intermediate
Quats (eg, benzethonium
chloride, cetrimide)
+ ++ - - + Slow Not compatible with anionic
detergents
NOTE. +++ = excellent, ++ = good, + = fair, - = no activity or not sufficient activity.
PCMX, para-chloro-meta-xylenol; quats, quaternary ammonium compounds.
*Modified from Boyce JM, Pittet D. Heathcare Infection Control Practices Advisory Committee.45The 5 most commonly touched noncritical items in the patient envi-
ronment have been quantitatively shown to be bed rails, bed surfaces,
supply carts, overbed tables, and intravenous pumps.34 In contrast to
critical and some semicritical items, most noncritical reusable items
may be decontaminated where they are used and do not need to be
transported to a central processing area. There is virtually no docu-
mented risk of transmitting infectious agents to patients via noncriti-
cal items35 when they are used as noncritical items and do not
contact nonintact skin, mucous membranes, or sterile tissue. How-
ever, these items (eg, bedside tables, bed rails) could potentially con-
tribute to secondary transmission by contaminating hands of health
care providers or by contacting medical equipment that will subse-
quently come in contact with patients.36 Tables 1 and 4 list several
low-level disinfectants that may be used for noncritical items. Table 4
lists the advantages and disadvantages of the low-level disinfectants
that are used on noncritical patient care items (eg, blood pressure
cuffs) and noncritical environmental surfaces. The exposure time for
low-level disinfection of noncritical items is at least 1 minute.
Many Environmental Protection Agency−registered liquid disin-
fectants have a 10-minute label claim. However, multiple investiga-
tors have demonstrated the effectiveness of these disinfectants
against vegetative bacteria (eg, Listeria, Escherichia coli, Salmonella,
vancomycin-resistant enterococci, methicillin-resistant Staphylococ-
cus aureus), yeasts (eg, Candida), mycobacteria (eg, Mycobacterium
tuberculosis), and viruses (eg, poliovirus) at exposure times of 30-60
seconds.5,37-42 Thus, it is acceptable from a microbial inactivation per-
spective to disinfect noncritical medical equipment (eg, blood pres-
sure cuffs) and noncritical surfaces (eg, bedside tables) with an
Environmental Protection Agency−registered disinfectant or disinfec-
tant/detergent at the proper use dilution and a contact time of ≥1
minute.5,43,44 Since the typical drying time for a liquid disinfectant or
disinfectant towelette on a surface is 1-4 minutes42 and microbial
inactivation occurs in 30-60 seconds,40,42 one application of the disin-
fectant with a contact time of ≥1 minute on all hand contact or touch-
able noncritical surfaces is recommended.
ANTISEPSIS
Antiseptics are used in health care to reduce the level of microor-
ganisms on the skin to a level unlikely to allow transfer from providers
to patients (eg, cross-transmission via hands) or be the nidus of infec-
tion (eg, skin preparation prior to insertion of an intravascular device).
Table 5 summarizes the antimicrobial spectrum of the antiseptics most
commonly used in health care.45 Bacterial spores are not listed, as theyare not susceptible to available antiseptics and can only be removed
mechanically by hand hygiene with soap and water or scrubbing. The
most commonly used antiseptics in health care are chlorhexidine
(CHG) (alone or in combination with alcohol), alcohol (alone or in com-
bination with CHG or iodophor), and iodophor (alone or in combination
with alcohol). Antiseptics are used for microbial reduction on skin in
the following ways: hand hygiene, preoperative showers, preoperative
skin preparation, skin preparation prior to insertion of catheters, and
routine daily bathing of patients. Regarding this issue, Boyce reviewed
several important topics associated with the use of antiseptics to
include: current issues in hand hygiene; daily CHG treatment in the
intensive care unit; prevention of infection during intravascular access,
and best products for skin antisepsis for preoperative bathing, surgical
site preparation, and surgical hand scrubs. Antiseptics (10% povidone-
iodine) have also been used to decontaminate bone, with minimum
sacrifice of cell viability, after dropping a bone graft on the operating
room floor.53,54CONCLUSIONS
When properly used, disinfection and sterilization can ensure the
safe use of invasive and noninvasive medical devices. Cleaning should
always precede high-level disinfection and sterilization. Strict adher-
ence to current disinfection and sterilization guidelines is essential to
prevent patient infections and exposures to infectious agents.References
1. Fields R. Outpatient surgeries outnumber inpatient surgeries at 53M procedures a
year. Available from: https://www.beckersasc.com/news-analysis/outpatient-sur-
geries-outnumber-inpatient-surgeries-at-53m-procedures-a-year.html. Accessed
January 2019.
2. Peery AF, Dellon ES, Lund JC, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Bur-
den of gastrointestinal disease in the United States: 2012 update. Gastroenterol-
ogy 2012;143:1179-87.
3. Rutala WA, Weber DJ. Outbreaks of carbapenem-resistant Enterobacteriaceae
infections associated with duodenoscopes: what can we do to prevent infections?
Am J Infect Control 2016;44(Suppl):47-51.
4. Rutala WA, Weber DJ. Disinfection and sterilization: an overview. Am J Infect Con-
trol 2013;41(Suppl):2-5.
5. Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee.
Guideline for disinfection and sterilization in healthcare facilities, 2008 Centers for
Disease Control and Prevention. Available from: https://www.cdc.gov/infection-
control/pdf/guidelines/disinfection-guidelines.pdf. Accessed January 2019.
6. Rutala WA, Weber DJ. Disinfection, sterilization, and antisepsis: an overview. Am J
Infect Control 2016;44(Suppl):1-6.
7. Rutala WA, Weber DJ. Disinfection, sterilization, and control of hospital waste. In:
Bennett JE, Dolan R, Blaser MJ, editors. Principles and practice of infectious dis-
eases. Philadelphia (PA): Elsevier. In press.
8. Spaulding EH. Chemical disinfection of medical and surgical materials. In:
Lawrence C, Block SS, eds. Disinfection, sterilization, and preservation. Philadel-
phia (PA): Lea & Febiger; 1968:517-31.
9. Simmons BP. CDC guidelines for the prevention and control of nosocomial infec-
tions. Guideline for hospital environmental control. Am J Infect Control
1983;11:97-120.
10. Rutala WA. APIC guideline for selection and use of disinfectants. 1994, 1995, and
1996 APIC Guidelines Committee. Association for Professionals in Infection Control
and Epidemiology, Inc. Am J Infect Control 1996;24:313-42.
11. McDonnell G, Burke P. Disinfection: is it time to reconsider Spaulding? J Hosp
Infect 2011;78:163-70.
12. Alfa MJ, DeGagne P, Olson N, Puchalski T. Comparison of ion plasma, vaporized
hydrogen peroxide, and 100% ethylene oxide sterilizers to the 12/88 ethylene
oxide gas sterilizer. Infect Control Hosp Epidemiol 1996;17:92-100.
13. Rutala WA, Gergen MF, Weber DJ. Efficacy of a washer-disinfector in eliminating
healthcare-associated pathogens from surgical instruments. Infect Control Hosp
Epidemiol 2014;35:883-5.
14. Alfa MJ. Monitoring and improving the effectiveness of cleaning medical and sur-
gical devices. Am J Infect Control 2013;41(Suppl):56-9.
15. Seavey R. High-level disinfection, sterilization, and antisepsis: current issues in
reprocessing medical and surgical instruments. Am J Infect Control 2013;41
(Suppl):111-7.
16. Food and Drug Administration. Infections associated with reprocessed duodeno-
scopes. Available from: https://www.fda.gov/medicaldevices/productsandmedi-
calprocedures/reprocessingofreusablemedicaldevices/ucm454630.htm#meeting.
Accessed January 2019.
17. Rutala WA, Kanamori H, Gergen MF, Sickbert-Bennett EE, Weber DJ. What’s new in
reprocessing endoscopes: are we going to ensure “the needs of the patient come
first” by shifting from disinfection to sterilization? Am J Infect Control 2019;47
(Suppl):A62-6.
18. Rutala WA, Weber DJ. ERCP scopes: what can we do to prevent infections? Infect
Control Hosp Epidemiol 2015;36:643-8.
19. Rutala WA, Weber DJ. Gastrointestinal endoscopes: a need to shift from disinfec-
tion to sterilization? JAMA 2014;312:1405-6.
20. Rutala WA, Weber DJ. Reprocessing semicritical items: current issues and new
technologies. Am J Infect Control 2016;44(Suppl):53-62.
21. Rutala WA, Weber DJ. New developments in reprocessing semicritical items. Am J
Infect Control 2013;41(Suppl):60-6.
22. Rutala WA, Gergen MF, Weber DJ. Disinfection of a probe used in ultrasound-
guided prostate biopsy. Infect Control Hosp Epidemiol 2007;28:916-9.
23. Rutala WA, Gergen MF, Weber DJ. Disinfection of an infrared coagulation device
used to treat hemorrhoids. Am J Infect Control 2012;40:78-9.
24. Food and Drug Administration. FDA-cleared sterilants and high level disinfectants
with general claims for processing reusable medical and dental devices. Available
from: https://www.fda.gov/medicaldevices/deviceregulationandguidance/reproc-
essingofreusablemedicaldevices/ucm437347.htm. Accessed January 2019.
25. Rutala WA, Weber DJ. Reprocessing semicritical items: outbreaks and current
issues. Am J Infect Control 2019;47(Suppl):A79-89.
26. Rutala WA, Weber DJ. How to assess risk of disease transmission to patients when
there is a failure to follow recommended disinfection and sterilization guidelines.
Infect Control Hosp Epidemiol 2007;28:146-55.
27. Sehulster L, Chinn RY. Centers for Disease Control and Prevention. Healthcare
Infection Control Practices Advisory Committee. Guidelines for environmental
infection control in health-care facilities. Recommendations of CDC and the
Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR
Recomm Rep 2003;52:1-42.
28. Thompson J, Garrett JH Jr. Transducer disinfection for assessment and insertion of
peripheral and central catheters. Available from: https://www.avainfo.org/page/
UltrasoundDisinfect. Accessed January 21, 2019.
29. Kanamori H, Rutala WA, Weber DJ. The role of patient care items as a fomite in
healthcare-associated outbreaks and infection prevention. Clin Infect Dis
2017;65:1412-9.
30. John A, Alhmidi H, Cadnum JL, Jencson AL, Donskey CJ. Contaminated portable
equipment is a potential vector for dissemination of pathogens in the intensive
care unit. Infect Control Hosp Epidemiol 2017;38:1247-9.31. Suwantarat N, Supple LA, Cadnum JL, Sankar T, Donskey CJ. Quantitative assess-
ment on interactions between hospitalized patients and portable medical equip-
ment and other fomites. Am J Infect Control 2017;45:1276-8.
32. Deshpande A, Cadnum JL, Fertelli D, Sitzlar B, Thota P, Mana TS, et al. Are hospital
floors an underappreciated reservoir for transmission of health care−associated
pathogens. Am J Infect Control 2017;45:336-8.
33. Koganti S, Alhmidi H, Tomas ME, Cadnum JL, Jencson A, Donskey CJ. Evaluation of
hospital floors as a potential source of pathogen dissemination using a nonpatho-
genic virus as a surrogate marker. Infect Control Hosp Epidemiol 2016;37:1374-7.
34. Huslage K, Rutala WA, Sickbert-Bennett E, Weber DJ. A quantitative approach to
defining “high-touch” surfaces in hospitals. Infect Control Hosp Epidemiol
2010;31:850-3.
35. Weber DJ, Rutala WA. Environmental issues and nosocomial infections. In:
Wenzel RP, ed. Prevention and control of nosocomial infections, 3rd ed Baltimore
(MD): Williams andWilkins; 1997:491-514.
36. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital
surfaces in the transmission of emerging health care−associated pathogens: noro-
virus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010;38
(Suppl):25-33.
37. Best M, Sattar SA, Springthorpe VS, Kennedy ME. Efficacies of selected disinfec-
tants againstMycobacterium tuberculosis. J Clin Microbiol 1990;28:2234-9.
38. Best M, Kennedy ME, Coates F. Efficacy of a variety of disinfectants against Listeria
spp. Appl Environ Microbiol 1990;56:377-80.
39. Best M, Springthorpe VS, Sattar SA. Feasibility of a combined carrier test for disin-
fectants: studies with a mixture of five types of microorganisms. Am J Infect Con-
trol 1994;22:152-62.
40. Rutala WA, Barbee SL, Aguiar NC, Sobsey MD, Weber DJ. Antimicrobial activity of
home disinfectants and natural products against potential human pathogens.
Infect Control Hosp Epidemiol 2000;21:33-8.
41. Rutala WA, Gergen MF, Weber DJ. Efficacy of improved hydrogen peroxide against
important healthcare-associated pathogens. Infect Control Hosp Epidemiol
2012;33:1159-61.
42. West AM, Teska PJ, Oliver HF. There is no additional bactericidal efficacy of Envi-
ronmental Protection Agency−registered disinfectant towelettes after surface dry-
ing or beyond label contact time. Am J Infect Control 2019;47:27-32.
43. Rutala WA, Weber DJ. Selection of the ideal disinfectant. Infect Control Hosp Epi-
demiol 2014;35:855-65.
44. Rutala WA, Weber DJ. Surface disinfection: treatment time (wipes/sprays) versus
contact time (liquids). Infect Control Hosp Epidemiol 2018;39:329-31.
45. Boyce JM, Pittet D. Healthcare Infection Control Practices Advisory Committee. Soci-
ety for Healthcare Epidemiology of America. Association for Professionals in Infec-
tion Control. Infectious Diseases Society of America. Hand Hygiene Task Force.
Guideline for hand hygiene in health-care settings: recommendations of the Health-
care Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/
IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002;23(Suppl):3-40.
46. Rutala WA, Weber DJ. Cleaning, disinfection and sterilization. In: Grota P, ed. APIC
text of infection control and epidemiology, 4th ed Washington (DC): Association
for Professionals in Infection Control and Epidemiology; 2014:1-15.
47. Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: an
overview and current issues. Infect Dis Clin North Am 2016;30:609-37.
48. Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: what
clinicians need to know. Clin Infect Dis 2004;39:702-9.
49. Kohn WG, Collins AS, Cleveland JL, Harte JA, Eklund KJ, Malvitz DM. Centers for
Disease Control and Prevention. Guidelines for infection control in dental health-
care settings—2003. MMWR Recomm Rep 2003;52:1-61.
50. Rutala WA, Weber DJ. Guideline for disinfection and sterilization of prion-contam-
inated medical instruments. Infect Control Hosp Epidemiol 2010;31:107-17.
51. Weber DJ, Rutala WA, Sickbert-Bennett EE. Outbreaks associated with contaminated
antiseptics and disinfectants. Antimicrob Agents Chemother 2007;51:4217-24.
52. Rutala WA, Cole EC, Thomann CA, Weber DJ. Stability and bactericidal activity of
chlorine solutions. Infect Control Hosp Epidemiol 1998;19:323-7.
53. Bruce B, Sheibani-Rad S, Appleyard D, Calfee RP, Reinert SE, Chapin KC, et al. Are
dropped osteoarticular bone fragments safely reimplantable in vivo? J Bone Joint
Surg Am 2011;93:430-8.
54. Bauer J, Liu RW, Kean TJ, Dennis JE, Petersilige W, Gilmore A. A comparison of five
treatment protocols for contaminated bone grafts in reference to sterility and cell
viability. J Bone Joint Surg Am 2011;93:439-44.
